Santa Fe Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-37,114
Closed -$2.55M 46
2015
Q4
$2.55M Buy
37,114
+24,578
+196% +$1.62M 0.42% 85
2015
Q3
$743K Sell
12,536
-15,913
-56% -$1.01M 0.1% 301
2015
Q2
$1.89M Sell
28,449
-5,908
-17% -$389K 0.26% 161
2015
Q1
$2.22M Buy
+34,357
New +$2.15M 0.27% 131
2014
Q2
Sell
-39,622
Closed -$2.06M 496
2014
Q1
$2.06M Buy
+39,622
New +$2.11M 0.29% 150
2013
Q3
Sell
-33,749
Closed -$1.51M 473
2013
Q2
$1.51M Buy
+33,749
New +$1.47M 0.31% 130

Other funds holding BMY

Santa Fe Partners's BMY Position: Q1 2016 in Review

Santa Fe Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 37,114 shares — an estimated $2.55M sold.

Santa Fe Partners first reported a position in BMY in Q2 2013 and held it in 6 quarters. The position peaked at $2.55M in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • Santa Fe Partners reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 37,114 Bristol-Myers Squibb shares in Q1 2016, an estimated $2.55M.
  • Santa Fe Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 6 quarters.
  • Santa Fe Partners's Bristol-Myers Squibb position peaked at $2.55M in Q4 2015.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.